Literature DB >> 29557419

Intraductal Tubulopapillary Epithelial Proliferation Associated with Type 1 Autoimmune Pancreatitis.

Shinya Fujie1, Hiroyuki Matsubayashi2, Hirotoshi Ishiwatari1, Hiromasa Hazama1, Takaaki Ito3, Keiko Sasaki4, Hiroyuki Ono1.   

Abstract

A 70-year-old man was referred to our hospital with exacerbation of diabetes. His blood tests showed elevated levels of serum IgG4 and HbA1c. Computed tomography of the pancreatic body demonstrated a weakly enhanced mass, 2 cm in size, with indistinct borders. Magnetic resonance cholangiopancreatography revealed a narrowing of the main pancreatic duct (MPD) at the pancreatic body, a markedly dilated upstream duct, and a slightly dilated downstream duct. Endoscopic ultrasonography demonstrated an iso-hypoechoic heterogeneous mass, protruding and spreading in the pancreatic duct. The histology of a fine needle aspiration sample demonstrated fibrous tissue containing abundant IgG4-positive plasma cells and atypical epithelial cells. The imaging findings and histology were not typical for either pancreatic ductal adenocarcinoma or type 1 autoimmune pancreatitis (AIP), but these were not completely excluded, and a distal pancreatectomy was performed. Histological examination showed an intraductal tubulopapillary epithelial proliferation, which contained cytoplasmic mucin (MUC5AC and MUC6), and severe IgG4-positive lymphoplasmacytic infiltration in the interstitium around the MPD. Next-generation sequencing using DNA extracted from the tumor revealed no mutation of K-ras, GNAS, or TP53. The entire lesion was ultimately diagnosed as AIP with an intraductal tubular and papillary epithelial hyperplasia producing gastric-type mucin. Some recent reports have described AIP development in the background of intraductal papillary mucinous neoplasms, and some have hypothesized a paraneoplastic occurrence of IgG4-related disease. The current case indicates issues in the clinical diagnosis of rare variants of AIP, and raises questions about the relationship between AIP and pancreatic epithelial lesions.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29557419     DOI: 10.15403/jgld.2014.1121.271.fuj

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  4 in total

1.  Multilocular Cyst of Type 1 Autoimmune Pancreatitis Masquerading as Cancerization of Intraductal Papillary Mucinous Neoplasm.

Authors:  Junichi Kaneko; Hiroyuki Matsubayashi; Tatsunori Satoh; Junya Sato; Masaki Takinami; Hirotoshi Ishiwatari; Katsuhiko Uesaka; Masato Abe; Keiko Sasaki; Hiroyuki Ono
Journal:  Intern Med       Date:  2019-09-03       Impact factor: 1.271

Review 2.  Review of the Application of Nanovesicles and the Human Interstitial Fluid in Gastrointestinal Premalignant Lesion Detection, Diagnosis, Prognosis and Therapy.

Authors:  Yu Huang; Xin Deng; Jian Liang
Journal:  Int J Nanomedicine       Date:  2019-12-02

Review 3.  Steroid Therapy and Steroid Response in Autoimmune Pancreatitis.

Authors:  Hiroyuki Matsubayashi; Hirotoshi Ishiwatari; Kenichiro Imai; Yoshihiro Kishida; Sayo Ito; Kinichi Hotta; Yohei Yabuuchi; Masao Yoshida; Naomi Kakushima; Kohei Takizawa; Noboru Kawata; Hiroyuki Ono
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

4.  Type 1 Autoimmune Pancreatitis Extending along the Main Pancreatic Duct: IgG4-related Pancreatic Periductitis.

Authors:  Junya Sato; Hiroyuki Matsubayashi; Hirotoshi Ishiwatari; Tatsunori Satoh; Junichi Kaneko; Kazuma Ishikawa; Masao Yoshida; Kohei Takizawa; Yohei Yabuuchi; Yoshihiro Kishida; Kenichiro Imai; Kinichi Hotta; Katsuhiko Uesaka; Keiko Sasaki; Hiroyuki Ono
Journal:  Intern Med       Date:  2020-09-30       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.